文献速递白内障与屈光手术青光眼眼整形与眼眶

门诊眼科手术的成本效益分析

Cost Analysis of Outpatient Ophthalmic Procedures.
PubMed 文献 · Am J Ophthalmol · 2026-06-15

该成本效益分析以加州圣迭戈的门诊设施为对象,基于医保索赔数据选取9种常见眼科手术,结合内部财务记录与公开数据测算维持财务中性所需的最大术中时间。结果显示,门诊手术中心(ASC)的最大术中时间为11.9至117.2分钟,医院门诊部(HOPD)约为ASC的两倍,为54.5至160.8分钟。作者认为多数ASC手术的财务中性时间超过30分钟,ASC在财务上适合开展常见眼科手术。

要点

  • ASC维持财务中性的最大术中时间范围为11.9至117.2分钟。
  • HOPD的最大术中时间约为ASC的两倍,范围为54.5至160.8分钟。
  • 医保报销相对单次手术直接材料成本是最大术中时间的主要驱动因素。

核心结论

  • 在分析的ASC中,多数眼科手术维持财务中性的最大术中时间超过30分钟,提示ASC在财务上适合高效开展常见眼科手术。
  • 医保报销相对单次手术直接材料成本是最大术中时间的主要驱动因素,ASC因报销限制和较低医保设施费而面临独特财务考量。

研究设计与样本

  • 成本效益分析,研究对象为加州圣迭戈的门诊设施,包括ASC和HOPD。
  • 采用基于维持财务中性所需最大术中时间的新框架,常见眼科手术依据保险索赔数据选取。
  • 各手术总成本由内部财务记录、既定运营框架和公开数据综合确定,并与公开的2025年及以后医保设施报销率比较。

主要发现

  • 纳入9种常见眼科手术:白内障摘除联合人工晶状体植入、巩膜外板储液器房水引流管、上睑眼袋切除术、泪囊鼻腔吻合术、小梁切除术、穿透性角膜移植术、上睑下垂修复术、斜视修复术和机械性平坦部玻璃体切除术。
  • ASC的最大术中时间从117.2分钟(巩膜外赤道板储液器房水引流管)到11.9分钟(玻璃体切除术)。
  • HOPD的最大术中时间多数约为ASC的两倍,从160.8分钟(巩膜外板储液器房水引流管;CPT 66180)到54.5分钟(上睑眼袋切除术;CPT 15823)。

关键数值与推荐

  • ASC最大术中时间范围为11.9至117.2分钟,由医保设施报销和单次手术直接材料成本驱动。
  • HOPD最大术中时间范围为54.5至160.8分钟,多数手术约为ASC的两倍。

临床怎么用

  • 该框架可用于评估ASC开展眼科手术的成本效益,为未来手术选择提供参考。
  • 研究结果支持讨论在ASC而非传统医院手术室开展眼科手术的可行性与效用,以促进公平的医疗可及性。

局限性

  • 研究对象仅为加州圣迭戈的门诊设施,外部推广需谨慎。
  • 成本测算依赖内部财务记录、既定运营框架和公开数据,可能存在不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE OR PURPOSE: To evaluate the financial feasibility of various ophthalmic procedures performed at outpatient facilities, including ambulatory surgical centers (ASCs) and hospital outpatient departments (HOPDs), relative to Medicare facility reimbursement in 2025 and beyond. DESIGN: Cost-efficiency analysis. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Outpatient facilities in San Diego, California. METHODS, INTERVENTION, OR TESTING: In this study, we propose a novel framework to analyze ASCs and HOPDs based on the maximum intraoperative time to maintain financial neutrality. Common ophthalmic procedures were selected using insurance claims data. Total costs for each procedure were determined using a combination of internal financial records, defined operational frameworks, and publicly available data. These inputs were used to calculate the maximum intraoperative time for each procedure relative to the publicly available Medicare facility reimbursement rates. MAIN OUTCOME MEASURES: The primary outcome was the total intraoperative time required to maintain financial neutrality for 9 common ophthalmic surgical procedures. RESULTS: Common ophthalmic procedures included the following: cataract removal with insertion of intraocular lens, aqueous shunt to extraocular plate reservoir, upper eyelid blepharoplasty, dacryocystorhinostomy, trabeculectomy, penetrating keratoplasty, repair of blepharoptosis, strabismus repair, and mechanical pars plana vitrectomy. The maximum intraoperative time to maintain financial neutrality for ASCs ranged from 117.2 (aqueous shunt to extraocular equatorial plate reservoir) to 11.9 (vitrectomy) minutes and was driven by Medicare facility reimbursement and direct material cost per procedure. For HOPDs, the maximum intraoperative times were approximately twice as high for most procedures and ranged from 160.8 (aqueous shunt to extraocular equatorial plate reservoir; CPT 66180) to 54.5 (blepharoplasty, upper eyelid; CPT 15823) minutes. CONCLUSIONS: In this analysis, most ophthalmic procedures performed at the ASCs analyzed had a maximum intraoperative time to maintain financial neutrality of >30 minutes, indicating that ASCs are well positioned to offer common ophthalmic surgical procedures in a financially efficient manner. Our model finds that Medicare reimbursement relative to the direct material cost per procedure was the main driver of maximum intraoperative time, highlighting the unique financial considerations ASCs may face due to limitations on reimbursement and lower Medicare facility fees compared with HOPDs. These findings support the utility of this framework in evaluating the cost-efficiency of ASCs to inform future decisions on procedures to adopt. Furthermore, our findings identify areas of discussion regarding the feasibility and utility of performing ophthalmic procedures at ASCs rather than in traditional hospital-based operating rooms to promote equitable access to health care.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Moon EF, Meller LL, Korn BS, et al. Cost Analysis of Outpatient Ophthalmic Procedures. Am J Ophthalmol. 2026. PMID: 42297201. doi:10.1016/j.ajo.2026.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。